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The study of the interaction of the pancreatic inhibitor with different alkylated erivatives of a- and E-trypsin 
shows that: 1) TLCK~-trypsin forms a complex with pancreatic nhibitor in tris buffer and tris-ethano140% system. 
2) TLCK-a-trypsin and TLCK-TPCK-fl-trypsin have lost their ability to complex formation with pancreatic nhibitor. 
TLCK-ot-trypsin and TLCK-TPCK-#-trypsin are derivatives inwhich the "chymotryptic" active site is destroyed. The 
results presented in this paper prove the participation of the "chymotrypic'" active site in the interaction between 
trypsin and pancreatic nhibitor. This is the second interaction beside that of the electrostatic bond between Asp-117 
of trypsin and Lys-15 of the inhibitor which we proved earlier. 
1. In t roduct ion  
The study of the complex between a-, t- and ~k- 
trypsin and the pancreatic inhibitor showed that only 
one electrostatic bond is involved in complex forma- 
tion between trypsin and BPTI* [1] - the bond be- 
tween Asp-177, which is a specificity site carboxyl group 
of trypsin, binding positively charged substrates, and 
Lys-15 of pancreatic inhibitor. We were able to show 
that hydrophobic forces play an important role in the 
interaction between trypsin and BPTI. 
Comparison of the esterase activity of a-, B-trypsin 
and'their alkylated erivatives demonstrated that be- 
sides the specific tryptic active site responsible for 
hydrolysis of positively charged substrates, there is 
* Abbreviations: 
BPTI : basic pancreatic trypsin inhibitor 
TPCK : tosyl phenylalanine chloromethyl ketone 
TLCK : tosyl ysine chloromethyl ketone 
Ac-Tyr-OEt : acetyl Wrosine thyl ester 
Bz-Arg-OEt : benzoyl arginine thyl ester 
BAPA : NOt-benzoyl'dl'ar~nine-p t'nitr°anilide 
also a second active site in the trypsin molecule which 
possesses a chymotrypsin like specificity [2]. 
In the present study we succeeded in showing 
that complex formation between trypsin and pan- 
creatic inhibitor also includes the inhibition of the 
"chymotryptic" site of  trypsin. 
2. Experimental procedure 
2.1. Materials 
a-. and B-trypsin were isolated from commercial 
Worthington preparations according to the procedure 
of Schroeder and Shaw [3]. BPTI was purified ac- 
cording to the method of Dlouha et al. [4]. TLCK 
and TPCK were obtained from Sil~na Chemical Com- 
pany. Bz -Arg -OEt  was a product of Fluka AG. Ac -  
Tyr -OEt  was obtained from Schuchardt. BAPA was 
purchased from Mann Research Laboratories. Sepha- 
dex derivatives were obtained from Pharmacia. 
2.2. Methods 
Inhibition o f  trypsin by TLCK was performed 
according to Shaw et al. [5]. 
Substituffon o f  B-trypsin with TPCK : 2 mg of 
North-Holland Publishing Company - Amsterdam 345 
Volume 12, number 6 FEBS LETTERS February 1971 
0 300 II 
o.~o- 
0100 - ,;__ 
9000 ~ , ' Y  
20 40 60 
TUBE 
60 70 
NUMBER 
i 
(a) 
~0 
300 
z 
40 ~ 200- 
3o ~ 
'20 1.00- 
.10 
0.00 
- -  I t t i | 
[ (b) 
20 
l I'0 2'0 '0 4'0 '~ 
TUBE NUMBER 
Fig. 1. Gel filtration of  BPTI and TLCK-O-trypsin complex on (a) Sephadex G-75 (column 1.0 X 45 cm) in 0.05 M tris 0.02 M 
CaCI 2 buffer pH 8.3 at room temperature and (b) Sephadex G-100(column 1.0 X 45 cm) in 0.05 M tris 0.02 M CaCI 2 buffer 
pH 8.3, 40% ethanol at room temperature. Flow rate: 1.5 ml per hr; 0.5 ml were collected per tube. ~---o: inhibition of  &trypsin 
by the samples; • - - - A; inhibition of #-trypsin by the samples after their treatment with 5% TCA. 
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Fig. 2 .Gel  ~t ra t ion  of  BTPI and TLCK-Ot-trypsin* mixture on (a) Sephadex G-75 (column 1.0 X 45 cm) in 0.05 M tris 0.02 M 
CaCI 2 buffer pH 8.3. o o absorbancy at 280 nm; -" -" inhibition of B-trypsin by the samples. (b) Sephadex G-100 (column 
1.0 X 45 cm) in 0.05 M tris 0.02 M CaC12 buffer pH 8.3, 40% ethanol at room temperature. Flow rate: 1.8 ml per hr; 0.6 ml were 
collected per tube: o o: inhibition of  #-trypsin by the samples; -" -~: inhibition of  B-trypsin by the samples after their treat- 
ment  with 5% TCA. 
* Gel filtration of BPTI and TLCK-TPCK-B-trypsin mixture under the conditions of  fig. 2a gave identical results to fig. 2a. 
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/~-trypsin was dissolved in 10 ml of 0.05 M tris pH 7.1 
buffer containing 0.025 M CaCI2 and 0.001 M benz- 
amidine HC1. The solution was cooled in an ice-bath. 
Then 0.64 mg of TPCK dissolved in 0.3 ml of methanol 
were added with stirring. After 6 hr, the solution was 
dialysed against 0.01 M HC1 to remove benzamidine 
and excess of TPCK. The volume of the sample was 
then reduced to 2 ml by ultrafiltration. No precipita- 
tion of the protein was observed uring the entire 
procedure. 
Molarity of active trypsin was determined by titra- 
tion of the active site using the method of Chase and 
Shaw [6]. 
Esterase activity was measured titrimetrically [7] 
with the aid of a Radiometer type TTT 1 autotitrator 
fitted with a type ABU 1 autoburette. The titrations 
were carried out in a jacketed 5ml vessel at 25 ° under 
nitrogen using 0.05 N NaOH. The concentration f
substrate was 0.01 M. The measurements were per- 
formed in 0.05 M tris pH 8.3 buffer containing 0.02 M 
CaC12. Protein concentration was determined from 
the absorbance at280 nm. The absorption coefficient 
used for the calculation was e = 16.1 [8] ; molecular 
weight of trypsin was taken as 23,800. The values of 
the specific activity were then calculated on the basis 
of the molarity of active trypsin. 
Tests for BPTI-trypsin complex were carried out 
after precipitation of the trypsin moiety by 5% 
trichloroacetic a id according to a method escribed 
earlier [9]. 
3. Results and discussion 
The comparison of profiles presented in fig. la and 
b shows that TLCK~-trypsin forms a complex with 
BPTI in tris buffer as well as in tris-40% ethanol. This 
means that the alkylation of His-46 with TLCK does 
not protect/3-trypsin from the interaction with 
pancreatic nhibitor. The data presented in table 1 
confirm the results obtained by chromatography. 
Complete inhibition of TLCK-/3-trypsin esterase activ- 
ity was observed in the presence of BPTI. 
In contrast to/3-trypsin, substitution of a-trypsin 
with TLCK leads to a complete loss of its esterase 
activity (table 1). Gel filtration of a mixture of TLCK- 
a-trypsin and a molar excess of BPTI (fig. 2) proved 
that no complex formation takes place between 
TLCK-a-trypsin and the pancreatic nhibitor. All 
inhibitory activity is concentrated in the second peak 
which corresponds toan excess of free inhibitor. 
As is well known, a-trypsin differs from the/3-form 
in the cleavage of one bond between Lys-131 and 
Ser-132 [3]. In our previous work we were able to 
show that this particular cleavage destroys the 
"chymotryptic" active site of the trypsin molecule 
[2]. We have also proved that only one electrostatic 
bond exists between Asp-177 of trypsin and Lys-15 
of the inhibitor and that the other interactions are 
due to hydrophobic forces [1 ]. Alkylation of His-46 
in a- and/3-trypsin with TLCK leads to the same 
chemical modification resulting in the inactivation 
of the specific tryptic active site which is responsible 
for cleavage of positively charged substrates. On the 
other hand, the difference between a- and/3-forms 
consists in their "chymotryptic" active site. The 
complex formation with pancreatic nhibitor was 
observed only in the case of TLCK-/3-trypsin, whose 
"chymotryptic" active site is not touched. In con- 
trast to the/3-form, TLCK-a-trypsin has completely 
lost its affinity for BPTI as a result of the disarrange- 
ment of its "chymotryptic" active site. 
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Fig. 3. Gel filtration of BPTI and TLCK-TPCK-#-trypsin 
mixture on Sephadex G-100 (column 1.0 X 45 cm) in 0.05 
M tris 0.02 M CaCI 2 buffer pH 8.3, 40% ethanol. Conditions 
were as in fig. 1. 
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Table 1 
Influence of BPTI on esterase activity of trypsin (TR) and its derivatives. 
February 1971 
Trypsin 
Molar ratio and 
derivatives BPTI/Trypsin 
Tris Tris-ethanol 40% 
Bz -Arg--OEt Ac -Tyr--OEt Bz-Arg--OEt Ac--Tyr-OEt 
S.A. S.A. S.A. S.A. 
6 201 30.3 196.5 ~-TR 
4 0 0 96.5 
0 190 15.5 116 Ot-TR 
4 0 0 0 
0 7.0 3.1 35.6 TLCK-#-TR 
4 0 0 0 
0 195 4.6 208 TPCK-#-TR 
4 0 0 0 
0 0 0 0 TLCK-TPCK-#-TR 
4 - -  * . . . .  
0 0 0 0 TLCK-t~-TR 
4 . . . . . .  
18.8 
8.35 
9.0 
0 
0 
0 
0 
0 
0 
0 
S.A. Specific activity was expressed in ~eq/min/mg. * not determined. 
The substitution of TLCK~-trypsin with TPCK 
brought about the same change of enzymatic properties 
as in the case of TLCK-ot-trypsin. As can be seen from 
table 1, TLCK-TPCK~-trypsin completely lost the 
esterase activity. The results presented in fig. 3 prove 
that it also lost the affinity for complex formation 
with pancreatic nhibitor. 
To summarize the results presented above, we can 
conclude that the second interaction between trypsin 
and pancreatic nhibitor occurs in the "chymotryptic" 
active site of trypsin. This is an interaction of hydro- 
phobic character. Consequently, during the complex 
formation between trypsin and pancreatic nhibitor 
the inhibition of two active sites occurs: 1) the inhibi- 
tion of the specific active site of trypsin by an electro- 
static interaction between Asp-177 of trypsin and 
Lys-15 of the inhibitor [1], 2) the inhibition of the non- 
specific "chymotryptic" active site of trypsin through 
a hydrophobic nteraction between hydrophobic resi- 
dues of trypsin and the inhibitor. 
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